Francesca F.
- Country
- Italy
- Department
- SC Dermatologia
Research Overview
- Evaluation of Long-Term Safety and Efficacy of GSK1070806 in Moderate to Severe Atopic Dermatitis: A Humanised IgG1 Kappa Monoclonal Antibody Against Interleukin 18 Study
- Phase 4 Study on Incidence of Squamous Cell Carcinoma and Long-term Safety of Tirbanibulin Ointment and Diclofenac Sodium Gel in Actinic Keratosis
- Efficacy and Safety Evaluation of GSK1070806 in Adults with Moderate to Severe Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study
Data & Insights
Has run more than one trial at 33 of 75 partner sites.
Specializations
Dermatological Conditions
This investigator specializes in the treatment and research of various dermatological conditions, with particular emphasis on atopic dermatitis and actinic keratosis.
- Moderate to severe atopic dermatitis management
- Skin cancer prevention and treatment
- Topical therapeutic interventions
The investigator's work encompasses both chronic inflammatory skin conditions and precancerous lesions.
Therapeutic Approaches
The investigator focuses on evaluating novel therapeutic interventions, including systemic treatments and topical applications for dermatological conditions.
- Long-term safety assessments
- Novel drug development
- Comparative treatment studies
Their research includes both innovative biological therapies and established treatment modalities.
Clinical Expertise
The investigator demonstrates particular interest in long-term disease management and safety monitoring of dermatological treatments.
- Treatment efficacy evaluation
- Safety profile assessment
- Clinical outcomes measurement
Their work emphasizes comprehensive patient care and therapeutic safety monitoring.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.